AlveoliX AG

Private

BernHealthcare & Life Scienceshttps://www.alveolix.com/

Last Round

Grant

Oct 1, 2024

Total Funding Raised

$2.07M

Company Overview

AlveoliX AG is a life sciences platforms and tools company that provides organ-on-chip in-vitro solutions aimed at improving preclinical decision-making.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Non-AI

Keywords

organ-on-chipOoClung-on-chipmicrophysiological systemsMPSpreclinical modelsanimal testing alternativein-vitro modelsdrug discoverymicrofluidicsbreathing simulation3Rs animal testingtoxicology testingdisease modelingbiotech equipmentcontract research organizationCROsafety assessment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AlveoliX AG Comps

Public and private peers based on sector, stage, and business model.

AlveoliX AG comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

AlveoliX AG Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Oct 1, 2024
Grant	Jun 14, 2022
Grant	May 1, 2021
Grant	Mar 19, 2019
Grant	Feb 1, 2016
Grant	Jan 13, 2015

View all Funding Rounds

Key People

Founding team and executive leadership

Andreas Hugi

CTO

Executive Team

AlveoliX AG Investors

Notable investors and investment history

AlveoliX AG investors
Investor	Rounds
Eureka Network	Grant
European Commission	Grant
Rannís - The Icelandic Centre for Research	Grant
Eurostars SME programme	Grant
Bern Economic Development Agency	Grant
Innosuisse	Grant
Venture Kick	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Feb 1, 2026
Monthly visitors grew 88% MoM, from 747 to 1.4K.
Jul 19, 2025
Grew 27% QoQ, from 11 to 14 employees.

View all signals

AlveoliX AG Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

AlveoliX AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AlveoliX AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersBern

Employee Range14

Year Founded2015

Last FundingOct 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.